PDS Biotechnology Corp Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PDS Biotechnology Corp stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $95.00K.
- PDS Biotechnology Corp stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $203.50K.
- PDS Biotechnology Corp stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $267.00K, a 56.23% decline year-over-year.
- PDS Biotechnology Corp stock issued during period, value, issued for services for fiscal 2024 was $5.00M, a 0.00% change from fiscal 2023.
- PDS Biotechnology Corp stock issued during period, value, issued for services for fiscal 2023 was $5.00M, a 0.00% change from fiscal 2022.
- PDS Biotechnology Corp stock issued during period, value, issued for services for fiscal 2022 was $5.00M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $95.00K 10-K · filed 2026-03-30 | |
| 2025-03-31 | $203.50K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $5.00M 10-K · filed 2025-03-27 | |
| 2024-06-30 | $267.00K 10-K · filed 2026-03-30 | |
| 2023-12-31 | $411.00K 10-K · filed 2025-03-27 | $5.00M 10-K · filed 2024-03-28 |
| 2023-06-30 | $610.00K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $5.00M 10-K · filed 2024-03-28 | $5.00M 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |